MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells
Abstract Prostate cancer is the most commonly diagnosed cancer in men with African American men disproportionally suffering from the burden of this disease. Biomarkers that could discriminate indolent from aggressive and drug resistance disease are lacking. MicroRNAs are small non-coding RNAs that a...
Guardado en:
Autores principales: | Patrice Cagle, Suryakant Niture, Anvesha Srivastava, Malathi Ramalinga, Rasha Aqeel, Leslimar Rios-Colon, Uchechukwu Chimeh, Simeng Suy, Sean P. Collins, Rajvir Dahiya, Deepak Kumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/955ba9b3dedc4b5f87e00625a4479c4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
KCNQ1OT1: An Oncogenic Long Noncoding RNA
por: Patrice Cagle, et al.
Publicado: (2021) -
MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8
por: Xinhong Ge, et al.
Publicado: (2021) -
PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
por: Darren J. Wozniak, et al.
Publicado: (2017) -
Acta Nº214
por: Banco Central de Chile
Publicado: (2019) -
Surgical outcomes of re-excimer laser phototherapeutic keratectomy (re-PTK)
por: Osamu Hieda, et al.
Publicado: (2021)